학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 264건 | 목록 1~20
Academic Journal
Gemzell-Danielsson K; Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; Cameron S; Chalmers Centre, NHS Lothian & University of Edinburgh, Edinburgh, UK.; Bombas T; Obstetric Unit, Coimbra University Hospital Center, Coimbra, Portugal.; Parachini M; International Federation of Professional Abortion and Contraception Associates (FIAPAC), Rome, Italy.; Lubusky M; Department of Obstetrics and Gynecology, Palacky University Hospital, Olomouc, Czech Republic.; Agostini A; La Conception, University Hospital, Marseille, France.; Kroeze S; Vrouwen Medisch Centrum, 's-Hertogenbosch, The Netherlands.; Favier M; Global Doctors for Choice, Cork, Ireland.; Chebbah M; Public Health Expertise, Medical Affairs Department, Paris, France.; Varlet AA; Public Health Expertise, Medical Affairs Department, Paris, France.; Verhagen L; Nordic Pharma, Medical Affairs Department, Hoofddorp, The Netherlands.; Fiala C; Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Gynmed Clinic, Vienna, Austria.
Publisher: Wiley Country of Publication: United States NLM ID: 0210174 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3479 (Electronic) Linking ISSN: 00207292 NLM ISO Abbreviation: Int J Gynaecol Obstet Subsets: MEDLINE
Academic Journal
van Aken ESM; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: interaction@nki.nl.; Gandhi AK; Department of Radiation Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India.; O'Cathail SM; School of Cancer Sciences, University of Glasgow, United Kingdom; CUH/UCC Cancer Centre, Cork University Hospital, Cork, Ireland.; Borst G; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health and Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Barriuso J; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (Imas12), Madrid, Spain.; Fokas E; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Germany.; Castelo-Branco L; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Ree AH; Department of Oncology, Akershus University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; de Azambuja E; Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B.), l'Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium.; Kroeze S; Radiation Oncology Center Mittelland, Cantonal Hospital Aarau, Aarau, Switzerland.; Colombo I; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Levy A; Université Paris-Saclay, Gustave Roussy, Département d'Oncologie-Radiothérapie, Villejuif, France.; Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Niyazi M; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.; Szutowicz E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.; Liposits G; Department of Clinical Oncology, Innlandet Hospital Trust, Gjøvik, Norway.; Verheij M; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Radiation Oncology, Radboud university medical center, Nijmegen, the Netherlands.; Ray-Coquard I; Centre Léon Bérard, Lyon, France; Laboratoire RESHAPE U1290, Lyon, France; Université Claude Bernard Lyon Est, Lyon, France.; Tarantino P; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.; Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy.; Boot P; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Belka C; Department of Radiation Oncology, University of Munich LMU, Munich, Germany.; Ruysscher D; Radiation Oncology Department, Maastro Clinic, Maastricht, the Netherlands; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, the Netherlands.; Pentheroudakis G; Scientific and Medical Division, ESMO - European Society for Medical Oncology, Lugano, Switzerland.; Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Lordick F; Department of Medicine II, University of Leipzig Medical Center, Cancer Center Central Germany (CCCG), Leipzig, Germany.; Ricardi U; University of Turin, Department of Oncology, Torino, Italy.; Martins-Branco D; Scientific and Medical Division, ESMO - European Society for Medical Oncology, Lugano, Switzerland.; Prelaj A; Oncologia Medica Toracica Department, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.; de Jong MC; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Devnani B; Radiation Oncology Department, AIIMS - All India Institute of Medical Sciences, Jodhpur, India.
Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Academic Journal
Eur J Nucl Med Mol Imaging
Solomonidou, Nantia; Germanou, Daphnie; Strouthos, Iosif; Karagiannis, Efstratios; Farolfi, Andrea; Koerber, Stefan A; Debus, Juergen; Peeken, Jan C; Vogel, Marco E; Vrachimis, Alexis; Spohn, Simon K B; Shelan, Mohamed; Aebersold, Daniel; Grosu, Anca-Ligia; Ceci, Francesco; Kroeze, Stephanie G C; Guckenberger, Matthias; Fanti, Stefano; Belka, Claus; Hruby, George; ... (2023). PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. European journal of nuclear medicine and molecular imaging, 50(8), pp. 2529-2536. Springer 10.1007/s00259-023-06185-5
Eur. J. Nucl. Med. Mol. Imaging 50, 2529-2536 (2023)
Academic Journal
Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. christian.trapp@med.uni-muenchen.de.; Aebersold DM; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Casuscelli J; Department of Urology, University Hospital, LMU Munich, Munich, Germany.; Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, Australia.; Eze C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Fanti S; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Farolfi A; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Fendler W; Department of Nuclear Medicine, University Hospital,University of Essen, Essen, Germany.; Grosu AL; Department of Radiation Oncology, Medical Center , University of Freiburg, Freiburg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Freiburg, Freiburg, Germany.; Guckenberger M; Department of Radiation Oncology, University Hospital, University of Zurich, Zurich, Switzerland.; Hruby G; Department of Radiation Oncology, Royal North Shore Hospital, University of Sydney, Sydney, Australia.; Kirste S; Department of Radiation Oncology, Medical Center , University of Freiburg, Freiburg, Germany.; Koerber SA; Department of Radiation Oncology, Barmherzige Brüder Hospital Regensburg, Regensburg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Kroeze S; Department of Radiation Oncology, University Hospital, University of Zurich, Zurich, Switzerland.; Peeken JC; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Rogowski P; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Scharl S; Department of Radiation Oncology, University of Ulm, Ulm, Germany.; Shelan M; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Spohn SKB; Department of Radiation Oncology, Medical Center , University of Freiburg, Freiburg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Freiburg, Freiburg, Germany.; Berta-Ottenstein-Programm, Medical Faculty, University of Freiburg, Freiburg, Germany.; Strouthos I; Department of Radiation Oncology, German Oncology Center, European University Cyprus, Nicosia, Cyprus.; Unterrainer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, USA.; Vogel M; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Wiegel T; Department of Radiation Oncology, University of Ulm, Ulm, Germany.; Zamboglou C; Department of Radiation Oncology, Medical Center , University of Freiburg, Freiburg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Freiburg, Freiburg, Germany.; Department of Radiation Oncology, German Oncology Center, European University Cyprus, Nicosia, Cyprus.; Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Academic Journal
van Aken ESM; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: interaction@nki.nl.; Devnani B; Radiation Oncology Department, AIIMS - All India Institute of Medical Sciences, Jodhpur, India.; Castelo-Branco L; Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland.; De Ruysscher D; Radiation Oncology Department, Maastro Clinic, Maastricht, the Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands.; Martins-Branco D; Scientific and Medical Division, ESMO - European Society for Medical Oncology, Lugano, Switzerland.; Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Muoio B; Division of Medical Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Belka C; Department of Radiation Oncology, University of Munich LMU, Munich, Germany.; Lordick F; Department of Medicine II, University of Leipzig Medical Center, Cancer Center Central Germany (CCCG), Leipzig, Germany.; Kroeze S; Radiation Oncology Center Mittelland, Cantonal Hospital Aarau, Aarau, Switzerland.; Pentheroudakis G; Scientific and Medical Division, ESMO - European Society for Medical Oncology, Lugano, Switzerland.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Ricardi U; Department of Oncology, University of Turin, Turin, Italy.; Gandhi AK; Department of Radiation Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India.; Prelaj A; Oncologia Medica Toracica Dept., Fondazione IRCCS - Istituto Nazionale Dei Tumori, Milan, Italy.; O'Cathail SM; School of Cancer Sciences, University of Glasgow, UK; CUH/UCC Cancer Centre, Cork University Hospital, Cork, Ireland.; de Jong MC; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Academic Journal
Scharl, Sophia; Zamboglou, Constantinos; Strouthos, Iosif; Farolfi, Andrea; Serani, Francesca; Lanzafame, Helena; Giuseppe Morganti, Alessio; Trapp, Christian; Koerber, Stefan A; Debus, Jürgen; Peeken, Jan C; Vogel, Marco M E; Vrachimis, Alexis; K B Spohn, Simon; Ruf, Juri; Grosu, Anca-Ligia; Ceci, Francesco; Fendler, Wolfgang P; Bartenstein, Peter; Kroeze, Stephanie G C; ... (2023). Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence-results of a retrospective study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 184, p. 109678. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2023.109678
Radiother. Oncol. 184:109678 (2023)
Academic Journal
JAMA Netw Open
Zamboglou, Constantinos; Peeken, Jan C; Janbain, Ali; Katsahian, Sandrine; Strouthos, Iosif; Ferentinos, Konstantinos; Farolfi, Andrea; Koerber, Stefan A; Debus, Juergen; Vogel, Marco E; Combs, Stephanie E; Vrachimis, Alexis; Morganti, Alessio Giuseppe; Spohn, Simon K B; Shelan, Mohamed; Aebersold, Daniel M; Grosu, Anca-Ligia; Ceci, Francesco; Henkenberens, Christoph; Kroeze, Stephanie G C; ... (2023). Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer. JAMA Network Open, 6(5), e2314748. American Medical Association 10.1001/jamanetworkopen.2023.14748
JAMA net. open 6:e2314748 (2023)
검색 결과 제한하기
제한된 항목
[검색어] Kroeze, S G C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어